Literature DB >> 17996702

Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Markus Hassler1, Shradha Singh, Wyatt W Yue, Maciej Luczynski, Rachid Lakbir, Francisco Sanchez-Sanchez, Thomas Bader, Laurence H Pearl, Sibylle Mittnacht.   

Abstract

The retinoblastoma susceptibility protein, Rb, has a key role in regulating cell-cycle progression via interactions involving the central "pocket" and C-terminal regions. While the N-terminal domain of Rb is dispensable for this function, it is nonetheless strongly conserved and harbors missense mutations found in hereditary retinoblastoma, indicating that disruption of its function is oncogenic. The crystal structure of the Rb N-terminal domain (RbN), reveals a globular entity formed by two rigidly connected cyclin-like folds. The similarity of RbN to the A and B boxes of the Rb pocket domain suggests that Rb evolved through domain duplication. Structural and functional analysis provides insight into oncogenicity of mutations in RbN and identifies a unique phosphorylation-regulated site of protein interaction. Additionally, this analysis suggests a coherent conformation for the Rb holoprotein in which RbN and pocket domains directly interact, and which can be modulated through ligand binding and possibly Rb phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996702      PMCID: PMC4944837          DOI: 10.1016/j.molcel.2007.08.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  51 in total

1.  p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.

Authors:  K Yamane; E Katayama; T Tsuruo
Journal:  Oncogene       Date:  2001-05-24       Impact factor: 9.867

2.  Role of the LXCXE binding site in Rb function.

Authors:  A Dahiya; M R Gavin; R X Luo; D C Dean
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.

Authors:  K Yamane; E Katayama; K Sugasawa; T Tsuruo
Journal:  Oncogene       Date:  2000-04-13       Impact factor: 9.867

5.  Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.

Authors:  Eric Batsché; Julien Desroches; Steve Bilodeau; Yves Gauthier; Jacques Drouin
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

6.  Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.

Authors:  Ulrich K Binné; Marie K Classon; Frederick A Dick; Wenyi Wei; Michael Rape; William G Kaelin; Anders M Näär; Nicholas J Dyson
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

7.  Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle.

Authors:  S Miyake; W R Sellers; M Safran; X Li; W Zhao; S R Grossman; J Gan; J A DeCaprio; P D Adams; W G Kaelin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

8.  Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors.

Authors:  Yanping Li; Xiaoling Wang; Xiaojing Zhang; David W Goodrich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

9.  Crystal structure of a TFIIB-TBP-TATA-element ternary complex.

Authors:  D B Nikolov; H Chen; E D Halay; A A Usheva; K Hisatake; D K Lee; R G Roeder; S K Burley
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

10.  Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation.

Authors:  Young-Hwa Goo; Soon-Young Na; Hao Zhang; Jianming Xu; SunHwa Hong; JaeHun Cheong; Soo-Kyung Lee; Jae Woon Lee
Journal:  J Biol Chem       Date:  2003-11-25       Impact factor: 5.157

View more
  35 in total

1.  Phosphorylation puts the pRb tumor suppressor into shape.

Authors:  Andreas M F Heilmann; Nicholas J Dyson
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control.

Authors:  Jason R Burke; Greg L Hura; Seth M Rubin
Journal:  Genes Dev       Date:  2012-05-08       Impact factor: 11.361

3.  Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.

Authors:  Jason R Burke; Alison J Deshong; Jeffrey G Pelton; Seth M Rubin
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

4.  A comprehensive method for detecting ubiquitinated substrates using TR-TUBE.

Authors:  Yukiko Yoshida; Yasushi Saeki; Arisa Murakami; Junko Kawawaki; Hikaru Tsuchiya; Hidehito Yoshihara; Mayumi Shindo; Keiji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

Review 5.  Conserved RB functions in development and tumor suppression.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

6.  Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Authors:  Satoko Iwahori; Morgan Hakki; Sunwen Chou; Robert F Kalejta
Journal:  J Biol Chem       Date:  2015-06-21       Impact factor: 5.157

7.  The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas.

Authors:  Sergiy I Borysov; Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

8.  Retinoblastoma family proteins: New players in DNA repair by non-homologous end-joining.

Authors:  Paul H Huang; Rebecca Cook; Georgia Zoumpoulidou; Maciej T Luczynski; Sibylle Mittnacht
Journal:  Mol Cell Oncol       Date:  2015-06-10

Review 9.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

Review 10.  Deciphering the retinoblastoma protein phosphorylation code.

Authors:  Seth M Rubin
Journal:  Trends Biochem Sci       Date:  2012-12-03       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.